Bioprocess development of the production of the mutant P-219-L human d-amino acid oxidase for high soluble fraction expression in recombinant Escherichia coli

Biochemical Engineering Journal

Volumn 52, Issue 2-3, 2010, Pages 236-247

  Abou El Magd, Rabab M ^a   Sasaki, Chizuru ^a   Kawazoe, Tomoya ^a   El Sayed, Salah M ^a   Yorita, Kazuko ^a   Shishido, Yuji ^a   Sakai, Takashi ^a   Nakamura, Yoshitoshi ^a   Fukui, Kiyoshi ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

Author keywords

Bioprocess development; Chaperon inducer; Fed batch culture; Human d amino acid oxidase; Structure activity relationship

Indexed keywords

BIOPROCESS DEVELOPMENT; CHAPERON INDUCER; D-AMINO ACID OXIDASE; FED-BATCH CULTURES; STRUCTURE ACTIVITY RELATIONSHIPS;

AMINO ACIDS; BIOREACTORS; CELL CULTURE; CELL GROWTH; DISSOLVED OXYGEN; ENZYME ACTIVITY; ENZYMES; ESCHERICHIA COLI; GENE ENCODING; GLUCOSE; GROWTH KINETICS; ISOMERS; LOW TEMPERATURE PRODUCTION; OPTIMIZATION; YEAST;

BATCH CELL CULTURE;

BENZYL ALCOHOL; DEXTRO AMINO ACID OXIDASE; DISSOLVED OXYGEN; GLUCOSE; NITROGEN;

ARTICLE; BIOPROCESS; BIOPROCESS DEVELOPMENT; CARBON SOURCE; CULTURE MEDIUM; ENZYME ACTIVITY; ENZYME SPECIFICITY; ESCHERICHIA COLI; FED BATCH REACTOR; FERMENTATION; GENE EXPRESSION; HEAT SHOCK RESPONSE; NUTRIENT LIMITATION; PRIORITY JOURNAL; PROCESS DEVELOPMENT; SITE DIRECTED MUTAGENESIS; STRUCTURE ACTIVITY RELATION; WESTERN BLOTTING; YEAST;

ESCHERICHIA COLI;

EID: 77957949840     PISSN: 1369703X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bej.2010.08.016     Document Type: Article

References (43)

1. Kawazoe T., Tsuge H., Pilone M.S., Fukui K. Crystal structure of human d-amino acid oxidase: context-dependent variability of the backbone conformation of the VAAGL hydrophobic stretch located at the si-face of the flavin ring. Protein Sci. 2006, 15:2708-2717.
2. Fukui K., Watanabe F., Shibata T., Miyake Y. Molecular cloning and sequence analysis of cDNAs encoding porcine kidney d-amino acid oxidase. Biochemistry 1987, 26:3612-3618.
3. Momoi K., Fukui K., Watanabe F., Miyake Y. Molecular cloning and sequence analysis of cDNA encoding human kidney d-amino acid oxidase. FEBS Lett. 1988, 238:180-184.
4. Fukui K., Momoi K., Watanabe F., Miyake Y. In vivo and in vitro expression of porcine d-amino acid oxidase: in vitro system for the synthesis of a functional enzyme. Biochemistry 1988, 27:6693-6697.
5. Fukui K., Miyake Y. Molecular cloning and chromosomal localization of a human gene encoding d-amino acid oxidase. J. Biol. Chem. 1992, 267:18631-18638.
6. Urai Y., Jinnouchi O., Kwak K.T., Suzue A., Nagahiro S., Fukui K. Gene expression of d-amino acid oxidase in cultured rat astrocytcs: regional and cell type specific expression. Neurosci. Lett. 2002, 324:101-104.
7. Park H.K., Shishido Y., Ichise-Shishido S., Kawazoe T., Ono K., Iwana S., Tomita Y., Yorita K., Sakai T., Fukui K. Potential role for astroglial d-amino acid oxidase in extracellular d-serine metabolism and cytotoxicity. J. Biochem. 2006, 139:295-304.
8. Sasamura T., Matsuda A., Kokuba Y. Effects of d-methionine containing solution on tumor cell growth in vitro. Arzneimittelforschung 1999, 49:541-543.
9. Sasamura T., Matsuda A., Kokuba Y. Determination of d-amino acid oxidase activity in tumor cells. Ann. Clin. Biochem. 2002, 39:595-598.
10. Stegman L.D., Zheng H., Neal E.R., Ben-Yoseph O., Pollegioni L., Pilone M.S., Ross B.D. Induction of cytotoxic oxidative stress by d-alanine in brain tumor cells expressing Rhodotorula gracilis d-amino acid oxidase: a cancer gene therapy strategy. Hum. Gene Ther. 1998, 9:185-193.
11. Fang J., Sawa T., Akaike T., Maeda H. Tumor-targeted delivery of polyethylene glycol-conjugated d-amino acid oxidase for antitumor therapy via enzymatic generation of hydrogen peroxide. Cancer Res. 2002, 62:3138-3143.
12. Fang J., Sawa T., Akaike T., Greish K., Maeda H. Enhancement of chemotherapeutic response of tumor cells by a heme oxygenase inhibitor, pegylated zinc protoporphyrin. Int. J. Cancer 2004, 109:1-8.
13. Katsuki H., Nonaka M., Shirakawa H., Kume T., Akaike A. Endogenous d-serine is involved in induction of neuronal death by N-methyl-d-aspartate and simulated ischemia in rat cerebrocortical slices. J. Pharmacol. Exp. Ther. 2004, 311:836-844.
14. Mothet J.P., Parent A.T., Wolosker H., Brady R.O., Linden D.J., Ferris C.D., Rogawaski M.A., Snyder S.H. d-Serine is an endogenous ligand for the glycine site of the N-methyl d-aspartate receptor. Proc. Natl. Acad. Sci. U.S.A. 2000, 97:4926-4931.
15. Iwana S., Kawazoe T., Park H.K., Tsuchiya K., Ono K., Yorita K., Sakai T., Kusumi T., Fukui K. Chlorpromazine oligomer is a potentially active substance that inhibits human d-amino acid oxidase, product of a susceptibility gene for schizophrenia. J. Enzyme Inhib. Med. Chem. 2008, 23:901-911.
16. Abou El-Magd R.M., Park H.K., Kawazoe T., Iwana S., Ono K., Chung S.P., Yorita K., Sakai T., Fukui K. The effect of risperidone on d-amino acid oxidase activity as a hypothesis for a novel mechanism of action in the treatment of Schizophrenia. J. Psychopharmacol. 2010, 24(7):1055-1067.
17. Molla G., Sacchi S., Bernasconi M.G., Pilone M.S., Fukui K., Pollegioni L. Characterization of human d-amino acid oxidase. FEBS Lett. 2006, 580:2358-2364.
18. Magasanik B. Catabolite repression. Cold Spring Harb. Symp. Quant. Biol. 1961, 26:249-256.
19. Horvath I., Glatz A., Varvasovszki V., Török Z., Páli T., Balogh G., Kovács E., Nádasdi L., Benkö S., Joó F., Vígh L. Membrane physical state controls the signaling mechanism of the heat shock response in Synechocystis PCC 6803: identification of hsp17 as a fluidity gene. Proc. Natl. Acad. Sci. U.S.A. 1998, 95:3513-3518.
20. Shigapova N., Török Z., Balogh G., Goloubinoff P., Vigh L., Horvath I. Membrane fluidization triggers membrane remodeling which affects the thermotolerance in Escherichia coli. Biochem. Biophys. Res. Commun. 2005, 328:1216-1223.
21. Terpe K. Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems. Appl. Microbiol. Biotechnol. 2006, 72:211-222.
22. Andersen D.C., Krummen L. Recombinant protein expression for therapeutic applications. Curr. Opin. Biotechnol. 2002, 13:117-123.
23. Schmidt F.R. Recombinant expression systems in the pharmaceutical industry. Appl. Microbiol. Biotechnol. 2004, 65:363-372.
24. Cornelis P. Expressing genes in different Escherichia coli compartments. Curr. Opin. Biotechnol. 2000, 11:450-454.
25. Lee S.Y., Choi J.H., Xu Z. Microbial cell-surface display. Trends Biotechnol. 2003, 21:45-52.
26. Choi J.H., Lee S.Y. Secretory and extracellular production of recombinant proteins using Escherichia coli. Appl. Microbiol. Biotechnol. 2004, 64:625-635.
27. Georgiou G., Segatori L. Preparative expression of secreted proteins in bacteria: status report and future prospects. Curr. Opin. Biotechnol. 2005, 16:538-545.
28. Reischer H., Schotola I., Striedner G., Pötschacher F., Bayer K. Evaluation of the GFP signal and its aptitude for novel on-line monitoring strategies of recombinant fermentation processes. J. Biotechnol. 2004, 108:115-125.
29. Khmel I.A. Regulation of expression of bacterial genes in the absence of active cell growth. Russ. J. Genet. 2005, 41:968-984.
30. Ihssen J., Egli T. Specific growth rate and not cell density controls the general stress response in Escherichia coli. Microbiology 2004, 150:1637-1648.
31. Warnecke T., Gill R.T. Organic acid toxicity, tolerance, and production in Escherichia coli biorefining applications. Microb. Cell. Fact. 2005, 4:25.
32. Riesenberg D. High-cell-density cultivation of Escherichia coli. Curr. Opin. Biotechnol. 1991, 2:380-384.
33. Deutscher J. The mechanism of carbon catabolite repression in bacteria. Curr. Opin. Microbiol. 2008, 11:87-93.
34. Romano D., Molla G., Pollegioni L., Marinelli F. Optimization of human d-amino acid oxidase expression in Escherichia coli. Protein Expr. Purif. 2009, 68(November (1)):72-78.
35. Lee S.Y. High cell-density culture of Escherichia coli. Trends Biotechnol. 1996, 14:98-105.
36. Hanning G., Makrides S.C. Strategies for optimizing heterologous protein expression in Escherichia coli. Trends Biotechnol. 1998, 16:54-60.
37. Rogl H., Kosemund K., Kuhlbrandt W., Collinson I. Refolding of Escherichia coli produced membrane protein inclusion bodies immobilised by nickel chelating chromatography. FEBS Lett. 1998, 432:21-26.
38. Baneyx F., Mujacic M. Recombinant protein folding and misfolding in Escherichia coli. Nat. Biotechnol. 2004, 22:1399-1408.
39. de Marco A., Vigh L., Diamant S., Goloubinoff P. Native folding of aggregation prone recombinant proteins in Escherichia coli by osmolytes, plasmid or benzyl alcohol overexpressed molecular chaperones. Cell Stress Chaperon 2005, 10:329-339.
40. MacDonald H.L, Neway J.O. Effects of medium quality on the expression of human interleukin-2 at high cell density in fermentor cultures of Escherichia coli K-12. Appl. Environ. Microbiol. 1990, 56:640-645.
41. Riesenberg D., Menzel K., Schulz V., Schumann K., Veith G., Zuber G., Knorre W.A. High cell density fermentation of recombinant Escherichia coli expressing human interferon alpha 1. Appl. Microbiol. Biotechnol. 1990, 34:77-82.
42. Korz D.J., Rinas U., Hellmuth K., Sanders E.A., Deckwer W.D. Simple fedbatch technique for high cell density cultivation of Escherichia coli. J. Biotechnol. 1995, 39:59-65.
43. Chou C.P. Engineering cell physiology to enhance recombinant protein production in Escherichia coli. Appl. Microbiol. Biotechnol. 2007, 76:521-532.